What is Standex International Corporation's earnings per share (EPS)?

Standex International Corporation (SXI) reported diluted earnings per share of $8.67 for fiscal year 2026. This represents a 86.9% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Standex International Corporation (SXI) Financials

SXI

FY2026 annual

Revenue $891.6M +12.8% YoY

Net Income $104.6M +81.4% YoY

EPS (Diluted) $8.67 +86.9% YoY

Free Cash Flow $64.4M +56.0% YoY

Market Cap $3.6B as of Oct 6, 2026

Price / Sales 4.0x on $891.6M revenue, FY2026

Price / Earnings 34.0x on $104.6M net income, FY2026

Price / Book 4.7x on $755.2M equity, Q4 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 6, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period FY2026, ended Jun 30, 2026 Reported Aug 14, 2026 Currency USD FYE June

Newest figures come from the 10-K for FY2026, filed Aug 14, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the SXI SEC filings page.

Standex International Corporation (SXI) reported $891.6M in revenue for fiscal year 2026, up 12.8% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI SXI FY2026 2026-10-01

Standex's 2026 recovery restored operating leverage, but the business now operates with materially more debt than before its 2025 expansion.

Operating margin nearly doubled from 11.8% in FY2025 to 21.7% in FY2026 while revenue rose from $790M to $892M. Gross margin also widened from 39.9% to 41.7%, so the profit rebound reflects more than sales volume alone: costs below gross profit were absorbed more efficiently, or the revenue mix improved.

Cash conversion improved but remained incomplete: operating cash flow increased from $70M to $90M in FY2026. Free cash flow of $64M remained below net income of $105M, showing that part of the accounting recovery was consumed by reinvestment rather than becoming immediately available cash.

The financing structure changed materially: total assets expanded to $1.57B in FY2025 as debt-to-equity rose from 0.2x in FY2024 to 0.8x. Debt-to-equity eased to 0.7x in FY2026, but the current ratio fell to 2.4x from 3.4x, indicating less short-term balance-sheet cushion despite continued coverage of current obligations.

Financial Health Signals

Financial Health Score 64/100

Scored against operating companies for FY2026. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Standex International Corporation's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

Standex International Corporation has an operating margin of 21.7%, meaning the company retains $22 of operating profit per $100 of revenue. This strong profitability earns a score of 80/100, reflecting efficient cost management and pricing power. This is up from 11.8% the prior year.

Growth

Standex International Corporation's revenue grew 12.8% year-over-year to $891.6M, a solid pace of expansion. This earns a growth score of 68/100.

Leverage

Standex International Corporation has a moderate D/E ratio of 0.69. This balance of debt and equity financing earns a leverage score of 38/100.

Liquidity

With a current ratio of 2.40, Standex International Corporation holds $2.40 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 69/100.

Cash Flow

Standex International Corporation has a free cash flow margin of 7.2%, earning a moderate score of 55/100. The company generates positive cash flow after capital investments, but with room for improvement.

Returns

Standex International Corporation earns a strong 13.9% return on equity (ROE), meaning it generates $14 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 71/100. This is up from 8.1% the prior year.

Altman Z-Score Safe

4.85

Standex International Corporation scores 4.85, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($3.6B) relative to total liabilities ($830.5M). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Neutral

6/9

Standex International Corporation passes 6 of 9 financial strength tests. 3 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Mixed

0.86x

For every $1 of reported earnings, Standex International Corporation generates $0.86 in operating cash flow ($89.6M OCF vs $104.6M net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.

Interest Coverage Safe

6.30x

Standex International Corporation earns $6.30 in operating income for every $1 of interest expense ($193.6M vs $30.7M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$228.3M

YoY+2.8%

QoQ+1.6%

5Y CAGR+5.3%

10Y CAGR+1.7%

Standex International Corporation generated $228.3M in revenue in Q4 2026. This represents an increase of 2.8% from the same quarter a year earlier. Against the prior quarter it is up 1.6%.

EBITDA

$47.0M

YoY+4.7%

QoQ-53.2%

5Y CAGR+8.8%

Standex International Corporation's EBITDA was $47.0M in Q4 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 4.7% from the same quarter a year earlier. Against the prior quarter it is down 53.2%.

Net Income

$20.5M

YoY+22.3%

QoQ-69.4%

5Y CAGR+8.0%

10Y CAGR+5.3%

Standex International Corporation reported $20.5M in net income in Q4 2026. This represents an increase of 22.3% from the same quarter a year earlier. Against the prior quarter it is down 69.4%.

EPS (Diluted)

$1.69

YoY+37.4%

QoQ-69.5%

5Y CAGR+8.4%

10Y CAGR+5.9%

Standex International Corporation earned $1.69 per diluted share (EPS) in Q4 2026. This represents an increase of 37.4% from the same quarter a year earlier. Against the prior quarter it is down 69.5%.

Cash & Balance Sheet

Free Cash Flow

$34.9M

YoY+40.5%

QoQ+466.9%

5Y CAGR+6.2%

Standex International Corporation generated $34.9M in free cash flow in Q4 2026, representing cash available after capex. This represents an increase of 40.5% from the same quarter a year earlier. Against the prior quarter it is up 466.9%.

Cash & Debt

$178.7M

YoY+71.0%

QoQ+72.3%

5Y CAGR+5.6%

10Y CAGR+3.9%

Standex International Corporation held $178.7M in cash against $518.0M in long-term debt as of Q4 2026.

Dividends Per Share

$0.34

QoQ0.0%

5Y CAGR+7.2%

Standex International Corporation paid $0.34 per share in dividends in Q4 2026. It is unchanged from the prior quarter.

Shares Outstanding

12M

YoY+0.4%

QoQ0.0%

5Y CAGR-0.2%

10Y CAGR-0.5%

Standex International Corporation had 12M shares outstanding in Q4 2026. This represents an increase of 0.4% from the same quarter a year earlier. It is unchanged from the prior quarter.

Margins & Returns

Gross Margin

42.7%

YoY+1.6pp

QoQ+1.8pp

5Y change+5.4pp

10Y change+8.2pp

Standex International Corporation's gross margin was 42.7% in Q4 2026, indicating the percentage of revenue retained after direct costs. This is up 1.6 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.8 percentage points.

Operating Margin

16.4%

YoY+0.8pp

QoQ-24.0pp

5Y change+3.7pp

Standex International Corporation's operating margin was 16.4% in Q4 2026, reflecting core business profitability. This is up 0.8 percentage points from the same quarter a year earlier. Against the prior quarter it is down 24.0 percentage points.

Net Margin

9.0%

YoY+1.4pp

QoQ-20.9pp

5Y change+1.1pp

10Y change+2.7pp

Standex International Corporation's net profit margin was 9.0% in Q4 2026, showing the share of revenue converted to profit. This is up 1.4 percentage points from the same quarter a year earlier. Against the prior quarter it is down 20.9 percentage points.

Return on Equity

2.7%

YoY+0.4pp

QoQ-6.2pp

5Y change0.0pp

10Y change-0.6pp

Standex International Corporation's ROE was 2.7% in Q4 2026, measuring profit generated per dollar of shareholder equity. This is up 0.4 percentage points from the same quarter a year earlier. Against the prior quarter it is down 6.2 percentage points.

Capital Allocation

Share Buybacks

$602K

YoY+85.8%

QoQ+30000.0%

5Y CAGR-34.5%

10Y CAGR-13.2%

Standex International Corporation spent $602K on share buybacks in Q4 2026, returning capital to shareholders by reducing shares outstanding. This represents an increase of 85.8% from the same quarter a year earlier. Against the prior quarter it is up 30000.0%.

Capital Expenditures

$5.5M

YoY-35.6%

QoQ-1.2%

5Y CAGR-2.1%

Standex International Corporation invested $5.5M in capex in Q4 2026, funding long-term assets and infrastructure. This represents a decrease of 35.6% from the same quarter a year earlier. Against the prior quarter it is down 1.2%.

R&D Spending

Not reported for Q4 2026.

SXI Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

SXI quarterly income statement

Metric	FY2610-K	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K
Revenue	$891.6M+12.8%	$790.1M+9.6%	$720.6M-2.8%	$741.0M+0.8%	$735.3M+12.1%	$656.2M+8.6%	$604.5M-5.5%	$639.9M+7.5%	$595.5M-8.1%	$647.9M-13.8%	$751.6M-2.7%	$772.1M+7.8%	$716.2M+6.4%	$673.4M+10.3%	$610.6M
Cost of Revenue	$519.6M+9.4%	$474.9M+8.3%	$438.6M-3.8%	$456.0M-2.0%	$465.4M+12.2%	$415.0M+6.7%	$389.1M-4.0%	$405.3M+9.7%	$369.5M-14.5%	$432.3M-13.4%	$499.3M-4.8%	$524.7M+9.8%	$477.9M+5.0%	$455.2M+11.3%	$408.9M
Gross Profit	$372.0M+18.0%	$315.2M+11.8%	$282.0M-1.1%	$285.1M+5.6%	$269.9M+11.9%	$241.3M+12.0%	$215.5M-8.2%	$234.7M+3.8%	$226.0M+4.8%	$215.6M-14.5%	$252.3M+1.9%	$247.5M+3.9%	$238.3M+9.2%	$218.2M+8.2%	$201.7M
R&D Expenses	$24.2M+14.2%	$21.2M+3.4%	$20.5M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$4.4M0.0%	$4.4M
SG&A Expenses	$219.3M+13.4%	$193.4M+14.0%	$169.6M-1.6%	$172.3M+1.4%	$169.9M+4.2%	$163.1M+9.8%	$148.5M-1.2%	$150.3M+6.9%	$140.7M-3.0%	$145.0M-14.8%	$170.2M+2.6%	$165.8M0.0%	$165.8M+7.9%	$153.6M+8.6%	$141.5M
Operating Income	$193.6M+106.9%	$93.5M-8.0%	$101.7M-40.5%	$171.1M+93.8%	$88.3M+49.2%	$59.2M-2.3%	$60.5M-23.8%	$79.5M+1.7%	$78.1M+37.3%	$56.9M-19.1%	$70.3M-10.6%	$78.6M+19.4%	$65.9M+6.4%	$61.9M-2.3%	$63.4M
EBITDA	$232.2M+80.0%	$129.0M-0.7%	$129.9M-34.9%	$199.6M+69.1%	$118.0M+27.7%	$92.4M-0.4%	$92.8M-14.7%	$108.8M+5.4%	$103.2M+38.1%	$74.7M-15.4%	$88.3M-7.4%	$95.3M+18.5%	$80.5M+4.3%	$77.1M+0.8%	$76.5M
Interest Expense	$30.7M+28.3%	$23.9M+426.7%	$4.5M-15.9%	$5.4M-8.0%	$5.9M-2.0%	$6.0M-19.8%	$7.5M-30.5%	$10.8M+34.0%	$8.0M+98.6%	$4.0M+40.8%	$2.9M-9.2%	$3.2M+40.6%	$2.2M-8.9%	$2.5M+8.3%	$2.3M
Income Tax	$34.3M+209.0%	$11.1M-48.5%	$21.5M-13.2%	$24.8M+25.2%	$19.8M+39.9%	$14.2M+8.4%	$13.1M-30.1%	$18.7M-50.9%	$38.0M+221.7%	$11.8M-27.5%	$16.3M-21.9%	$20.9M+15.6%	$18.1M+18.4%	$15.2M-2.9%	$15.7M
Net Income	$104.6M+81.4%	$57.7M-21.1%	$73.1M-47.4%	$139.0M+126.4%	$61.4M+68.3%	$36.5M+80.7%	$20.2M-70.3%	$67.9M+85.5%	$36.6M-21.4%	$46.5M-10.6%	$52.1M-4.9%	$54.7M+27.7%	$42.9M-4.4%	$44.8M+45.1%	$30.9M
EPS (Basic)	$8.69+85.7%	$4.68-24.8%	$6.22-47.2%	$11.77+129.4%	$5.13+71.0%	$3.00+82.9%	$1.64-69.6%	$5.40+87.5%	$2.88-21.7%	$3.68-10.5%	$4.11-5.1%	$4.33+27.7%	$3.39-5.0%	$3.57+44.5%	$2.47
EPS (Diluted)	$8.67+86.9%	$4.64-24.4%	$6.14-47.0%	$11.58+128.9%	$5.06+70.4%	$2.97+82.2%	$1.63-69.7%	$5.38+88.1%	$2.86-21.6%	$3.65-10.5%	$4.08-4.4%	$4.27+27.5%	$3.35-4.6%	$3.51+45.0%	$2.42
Diluted Shares (Avg)	12M+0.4%	12M+0.9%	12M-0.9%	12M-0.9%	12M-1.1%	12M-1.0%	12M-1.9%	13M-1.2%	13M+0.2%	13M-0.1%	13M-0.2%	13M+0.2%	13M0.0%	13M-0.1%	13M

Metric	Q4'2610-K	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q
Revenue	$228.3M+2.8%	$224.6M+8.1%	$221.3M+16.6%	$217.4M+27.6%	$222.0M+23.2%	$207.8M+17.2%	$189.8M+6.4%	$170.5M-7.7%
Cost of Revenue	$130.8M+0.1%	$132.7M+5.8%	$129.1M+9.1%	$127.0M+26.5%	$130.8M+18.0%	$125.3M+15.0%	$118.4M+10.9%	$100.4M-10.5%
Gross Profit	$97.4M+6.7%	$91.9M+11.5%	$92.2M+29.1%	$90.4M+29.1%	$91.3M+31.5%	$82.4M+20.7%	$71.4M-0.3%	$70.1M-3.5%
R&D Expenses	N/A	$5.6M+3.7%	N/A	N/A	N/A	$5.4M-65.2%	N/A	N/A
SG&A Expenses	$56.9M+8.1%	$52.4M+0.8%	$55.6M+21.8%	$54.4M+26.3%	$52.6M+28.4%	$52.0M+24.6%	$45.7M+5.5%	$43.0M-1.2%
Operating Income	$37.6M+8.1%	$90.8M+246.0%	$35.6M+320.3%	$29.6M+23.0%	$34.7M+27.9%	$26.3M+20.2%	$8.5M-67.2%	$24.1M-10.5%
EBITDA	$47.0M+4.7%	$100.3M+178.6%	$45.6M+168.5%	$39.5M+26.6%	$44.9M+31.4%	$36.0M+24.0%	$17.0M-48.1%	$31.2M-8.4%
Interest Expense	$6.6M-27.3%	$7.3M-12.4%	$7.9M+42.0%	$8.9M+812.2%	$9.0M+593.5%	$8.4M+781.2%	$5.6M+447.1%	$977K-23.4%
Income Tax	$8.5M-19.7%	$14.0M+370.1%	$6.5M+820.6%	$5.2M+4.1%	$10.6M+80.0%	-$5.2M-220.1%	$710K-86.9%	$5.0M-15.9%
Net Income	$20.5M+22.3%	$67.0M+206.1%	$2.1M+147.4%	$15.1M-17.3%	$16.8M-14.5%	$21.9M+38.5%	$857K-95.5%	$18.2M-3.3%
EPS (Basic)	$1.70+37.1%	$5.56+203.8%	$0.17+142.9%	$1.26-18.2%	$1.24-25.7%	$1.83+36.6%	$0.07-95.6%	$1.54-3.8%
EPS (Diluted)	$1.69+37.4%	$5.55+206.6%	$0.17+142.9%	$1.25-18.3%	$1.23-25.0%	$1.81+36.1%	$0.07-95.6%	$1.53-3.2%
Diluted Shares (Avg)	N/A	12M0.0%	12M+0.2%	12M+1.2%	N/A	12M+1.8%	12M+1.4%	12M-0.2%

SXI Balance Sheet

SXI quarterly balance sheet

Metric	FY2610-K	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K
Total Assets	$1.6B+1.2%	$1.6B+55.9%	$1.0B-1.9%	$1.0B+9.7%	$934.4M-2.9%	$962.2M+3.4%	$930.9M+1.0%	$921.9M+0.5%	$916.9M+5.7%	$867.7M+25.7%	$690.5M+4.8%	$659.1M+14.0%	$578.2M+13.2%	$510.6M+6.4%	$479.8M
Current Assets	$551.8M+14.7%	$480.9M+11.8%	$430.1M-11.0%	$483.3M+27.5%	$379.0M+1.2%	$374.4M+12.8%	$332.0M-0.6%	$333.9M-13.0%	$384.0M+6.4%	$360.9M+1.4%	$355.8M+6.1%	$335.4M+11.8%	$299.9M+16.1%	$258.3M+3.6%	$249.3M
Cash & Equivalents	$178.7M+71.0%	$104.5M-32.2%	$154.2M-21.2%	$195.7M+86.7%	$104.8M-23.1%	$136.4M+14.8%	$118.8M+27.6%	$93.1M-15.0%	$109.6M+23.8%	$88.6M-27.4%	$122.0M+26.9%	$96.1M+29.4%	$74.3M+45.4%	$51.1M-6.7%	$54.7M
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	$129.0M-0.8%	$130.0M+49.2%	$87.1M-11.6%	$98.5M-6.5%	$105.3M+14.7%	$91.9M+8.0%	$85.0M+11.4%	$76.3M-26.8%	$104.3M-12.6%	$119.4M+13.3%	$105.4M-2.7%	$108.3M+11.6%	$97.1M+18.6%	$81.8M+12.0%	$73.1M
Accounts Receivable	$172.9M+0.1%	$172.7M+42.3%	$121.4M-1.7%	$123.4M+5.4%	$117.1M+6.5%	$109.9M+11.9%	$98.2M-5.0%	$103.4M-13.7%	$119.8M-5.7%	$127.1M+22.2%	$104.0M-5.9%	$110.5M+2.6%	$107.7M+9.9%	$98.0M-1.4%	$99.4M
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$581.6M-4.7%	$610.3M+117.0%	$281.3M+6.2%	$264.8M-1.2%	$267.9M-3.6%	$278.1M+2.5%	$271.2M-1.0%	$273.8M+34.2%	$204.1M-15.9%	$242.7M+54.2%	$157.4M+1.7%	$154.7M+22.8%	$126.0M+12.6%	$111.9M+11.2%	$100.6M
Total Liabilities	$830.5M-2.9%	$855.2M+123.0%	$383.6M-8.1%	$417.5M-4.0%	$435.1M-4.5%	$455.8M-2.9%	$469.2M+2.6%	$457.6M-1.8%	$466.1M+1.6%	$459.0M+43.2%	$320.5M+3.2%	$310.5M+30.8%	$237.4M+8.1%	$219.6M-7.3%	$236.9M
Current Liabilities	$229.5M+37.5%	$167.0M+30.9%	$127.6M-9.5%	$141.0M-6.5%	$150.8M+4.9%	$143.7M+17.0%	$122.9M-13.2%	$141.6M-12.2%	$161.3M+0.9%	$160.0M+19.3%	$134.1M-3.4%	$138.8M-1.7%	$141.2M+19.2%	$118.5M+1.4%	$116.8M
Non-Current Liabilities	$601.0M-9.0%	$660.3M+157.9%	$256.0M-7.4%	$276.5M-2.7%	$284.3M-8.9%	$312.1M-9.9%	$346.4M+9.6%	$316.0M+3.7%	$304.8M+1.9%	$299.0M+60.4%	$186.4M+8.6%	$171.7M+78.4%	$96.3M-4.8%	$101.1M-15.8%	$120.1M
Long-Term Debt	$518.0M-6.3%	$552.5M+271.1%	$148.9M-14.2%	$173.4M-0.8%	$174.8M-12.4%	$199.5M+0.2%	$199.2M+0.8%	$197.6M+2.0%	$193.8M+0.9%	$192.0M+108.4%	$92.1M-9.5%	$101.8M+125.8%	$45.1M-10.0%	$50.1M+0.1%	$50.0M
Total Equity	$755.2M+6.1%	$711.7M+14.5%	$621.5M+2.3%	$607.4M+21.6%	$499.3M-1.4%	$506.4M+9.7%	$461.6M-0.6%	$464.3M+3.0%	$450.8M+10.3%	$408.7M+10.5%	$370.0M+6.1%	$348.6M+2.3%	$340.7M+17.1%	$291.0M+19.8%	$242.9M
Retained Earnings	$1.2B+7.9%	$1.1B+3.7%	$1.1B+5.7%	$1.0B+14.0%	$901.4M+5.7%	$852.5M+3.0%	$827.7M+1.1%	$818.3M+7.5%	$761.4M+6.3%	$716.6M+5.7%	$678.0M+7.1%	$632.9M+8.4%	$584.0M+7.0%	$546.0M+8.1%	$505.2M

Metric	Q4'2610-K	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q
Total Assets	$1.6B+1.2%	$1.5B-1.8%	$1.6B+4.8%	$1.6B+49.8%	$1.6B+55.9%	$1.6B+56.5%	$1.5B+47.5%	$1.0B+5.8%
Current Assets	$551.8M+14.7%	$482.7M-0.9%	$490.7M+5.6%	$487.6M+9.0%	$480.9M+11.8%	$486.9M+16.2%	$464.9M+6.6%	$447.1M+6.5%
Cash & Equivalents	$178.7M+71.0%	$103.7M-5.5%	$97.0M-19.9%	$98.7M-40.1%	$104.5M-32.2%	$109.8M-20.9%	$121.1M-14.9%	$164.6M+29.8%
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	$129.0M-0.8%	$129.6M+8.0%	$131.2M+26.2%	$135.8M+50.7%	$130.0M+49.2%	$120.0M+26.1%	$104.0M+5.5%	$90.1M-8.3%
Accounts Receivable	$172.9M+0.1%	$179.7M+5.8%	$176.6M+15.3%	$166.7M+40.4%	$172.7M+42.3%	$169.9M+41.0%	$153.2M+22.0%	$118.7M-6.7%
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$581.6M-4.7%	$585.5M-4.1%	$594.1M+1.3%	$599.9M+105.3%	$610.3M+117.0%	$610.7M+116.6%	$586.7M+109.3%	$292.2M+6.1%
Total Liabilities	$830.5M-2.9%	$772.6M-11.0%	$854.3M+3.3%	$847.2M+123.0%	$855.2M+123.0%	$867.6M+131.7%	$826.9M+115.1%	$379.9M-1.8%
Current Liabilities	$229.5M+37.5%	$158.4M+10.7%	$170.8M+23.6%	$169.7M+34.7%	$167.0M+30.9%	$143.1M+16.9%	$138.2M+5.8%	$126.0M-4.3%
Non-Current Liabilities	$601.0M-9.0%	$570.0M-18.2%	$638.9M-3.5%	$650.4M+156.2%	$660.3M+157.9%	$697.0M+176.4%	$662.1M+160.7%	$253.9M-0.5%
Long-Term Debt	$518.0M-6.3%	$472.8M-18.4%	$534.7M+0.1%	$544.6M+265.6%	$552.5M+271.1%	$579.4M+289.5%	$534.3M+259.4%	$149.0M+0.3%
Total Equity	$755.2M+6.1%	$754.2M+9.8%	$700.2M+6.7%	$707.7M+7.5%	$711.7M+14.5%	$686.9M+11.0%	$656.0M+5.7%	$658.0M+10.7%
Retained Earnings	$1.2B+7.9%	$1.2B+7.4%	$1.1B+3.5%	$1.1B+3.4%	$1.1B+3.7%	$1.1B+4.3%	$1.1B+3.8%	$1.1B+5.6%

SXI Cash Flow Statement

SXI quarterly cash flow statement

Metric	FY2610-K	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K
Operating Cash Flow	$89.6M+28.7%	$69.6M-24.9%	$92.7M+2.0%	$90.8M+16.8%	$77.7M-7.0%	$83.6M+76.9%	$47.2M-35.6%	$73.3M+13.0%	$64.9M+2.3%	$63.4M-21.0%	$80.3M+25.4%	$64.0M-8.9%	$70.3M+16.8%	$60.2M+37.8%	$43.7M
Depreciation & Amortization	$38.7M+9.1%	$35.4M+25.9%	$28.1M-1.2%	$28.5M-4.1%	$29.7M-10.7%	$33.2M+2.9%	$32.3M+10.3%	$29.3M+17.0%	$25.0M+40.5%	$17.8M-0.8%	$18.0M+7.6%	$16.7M+14.3%	$14.6M-4.2%	$15.2M+15.9%	$13.1M
Stock-Based Compensation	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$5.0M-1.3%	$5.1M+35.2%	$3.8M-43.2%	$6.6M+98.3%	$3.3M-13.3%	$3.9M
Capital Expenditures	$25.2M-11.1%	$28.3M+39.6%	$20.3M-16.4%	$24.3M+1.6%	$23.9M+9.8%	$21.8M+1.1%	$21.5M-33.8%	$32.5M+37.9%	$23.6M	N/A	N/A	N/A	N/A	N/A	$9.9M
Free Cash Flow	$64.4M+56.0%	$41.3M-43.0%	$72.4M+8.8%	$66.5M+23.6%	$53.8M-12.9%	$61.8M+140.4%	$25.7M-37.0%	$40.8M-1.3%	$41.4M	N/A	N/A	N/A	N/A	N/A	$33.7M
Investing Cash Flow	$43.1M+108.6%	-$503.4M-716.9%	-$61.6M-248.3%	$41.6M+233.9%	-$31.0M+20.6%	-$39.1M-6235.7%	-$617K+98.8%	-$49.7M-53.9%	-$32.3M+82.0%	-$179.1M-522.1%	-$28.8M+63.3%	-$78.5M-136.8%	-$33.2M+37.1%	-$52.7M-713.8%	$8.6M
Financing Cash Flow	-$56.6M-114.9%	$380.5M+649.8%	-$69.2M-72.8%	-$40.0M+42.3%	-$69.4M-118.8%	-$31.7M-67.2%	-$19.0M+50.3%	-$38.2M-220.7%	-$11.9M-114.1%	$84.7M+508.2%	-$20.7M-146.5%	$44.6M+400.7%	-$14.8M-35.9%	-$10.9M-14.4%	-$9.5M
Dividends Paid	$16.2M+7.7%	$15.0M+8.1%	$13.9M+7.1%	$13.0M+6.0%	$12.2M+7.0%	$11.4M+7.9%	$10.6M+7.9%	$9.8M+10.6%	$8.9M+13.2%	$7.9M+14.7%	$6.8M+216.2%	-$5.9M-20.7%	-$4.9M-22.7%	-$4.0M-14.8%	-$3.5M
Share Buybacks	$4.4M-55.6%	$9.9M-68.9%	$31.8M+24.7%	$25.5M-18.8%	$31.4M+48.2%	$21.2M+103.1%	$10.4M-68.7%	$33.4M+1159.2%	$2.7M-66.0%	$7.8M+38.5%	$5.6M-45.6%	$10.4M+32.9%	$7.8M-8.4%	$8.5M+54.1%	$5.5M

Metric	Q4'2610-K	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q
Operating Cash Flow	$40.4M+21.0%	$11.7M+23.1%	$20.6M+127.0%	$16.8M-4.3%	$33.4M+17.1%	$9.5M-60.8%	$9.1M-61.6%	$17.6M+8.6%
Depreciation & Amortization	$9.4M-7.1%	$9.4M-3.0%	$10.0M+17.4%	$9.8M+39.0%	$10.1M+44.8%	$9.7M+35.8%	$8.5M+23.5%	$7.1M-0.3%
Capital Expenditures	$5.5M-35.6%	$5.6M-7.9%	$7.7M+10.0%	$6.4M-4.5%	$8.6M+31.3%	$6.1M+17.3%	$7.0M+63.9%	$6.7M+55.0%
Free Cash Flow	$34.9M+40.5%	$6.2M+77.5%	$12.9M+516.1%	$10.4M-4.1%	$24.8M+12.9%	$3.5M-81.9%	$2.1M-89.2%	$10.8M-8.4%
Investing Cash Flow	-$5.1M+49.4%	$62.3M+197.5%	-$7.7M+98.2%	-$6.4M-0.7%	-$10.1M-31.5%	-$63.9M-289.3%	-$423.1M-9858.2%	-$6.3M+81.0%
Financing Cash Flow	$40.2M+229.8%	-$66.7M-261.1%	-$14.6M-103.9%	-$15.5M-147.0%	-$31.0M-818.5%	$41.4M+585.3%	$376.3M+5036.7%	-$6.3M+87.4%
Dividends Paid	$4.0M+5.6%	$4.2M+9.6%	$4.1M+6.8%	$3.8M+8.7%	$3.8M+8.8%	$3.8M+8.5%	$3.8M+7.9%	$3.5M+7.3%
Share Buybacks	$602K+85.8%	$2K	$56K-98.9%	$3.7M-14.6%	$324K+653.5%	$0-100.0%	$5.2M+15.8%	$4.4M-80.2%

Not reported in any period shown, so not listed: Stock-Based Compensation.

SXI Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

SXI quarterly financial ratios

Metric	FY2610-K	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K
Gross Margin	41.7%+1.8pp	39.9%+0.8pp	39.1%+0.7pp	38.5%+1.8pp	36.7%-0.1pp	36.8%+1.1pp	35.6%-1.0pp	36.7%-1.3pp	38.0%+4.7pp	33.3%-0.3pp	33.6%+1.5pp	32.0%-1.2pp	33.3%+0.9pp	32.4%-0.6pp	33.0%
Operating Margin	21.7%+9.9pp	11.8%-2.3pp	14.1%-9.0pp	23.1%+11.1pp	12.0%+3.0pp	9.0%-1.0pp	10.0%-2.4pp	12.4%-0.7pp	13.1%+4.3pp	8.8%-0.6pp	9.4%-0.8pp	10.2%+1.0pp	9.2%0.0pp	9.2%-1.2pp	10.4%
Net Margin	11.7%+4.4pp	7.3%-2.8pp	10.1%-8.6pp	18.8%+10.4pp	8.3%+2.8pp	5.6%+2.2pp	3.3%-7.3pp	10.6%+4.5pp	6.2%-1.0pp	7.2%+0.3pp	6.9%-0.2pp	7.1%+1.1pp	6.0%-0.7pp	6.7%+1.6pp	5.1%
Return on Equity	13.9%+5.7pp	8.1%-3.6pp	11.8%-11.1pp	22.9%+10.6pp	12.3%+5.1pp	7.2%+2.8pp	4.4%-10.3pp	14.6%+6.5pp	8.1%-3.3pp	11.4%-2.7pp	14.1%-1.6pp	15.7%+3.1pp	12.6%-2.8pp	15.4%+2.7pp	12.7%
Return on Assets	6.6%+2.9pp	3.7%-3.6pp	7.3%-6.3pp	13.6%+7.0pp	6.6%+2.8pp	3.8%+1.6pp	2.2%-5.2pp	7.4%+3.4pp	4.0%-1.4pp	5.4%-2.2pp	7.5%-0.8pp	8.3%+0.9pp	7.4%-1.4pp	8.8%+2.3pp	6.4%
Current Ratio	2.40-0.5x	2.88-0.5x	3.37-0.1x	3.43+0.9x	2.51-0.1x	2.60-0.1x	2.70+0.3x	2.360.0x	2.38+0.1x	2.26-0.4x	2.65+0.2x	2.42+0.3x	2.12-0.1x	2.180.0x	2.13
Debt-to-Equity	0.69-0.1x	0.78+0.5x	0.240.0x	0.29-0.1x	0.350.0x	0.390.0x	0.430.0x	0.430.0x	0.430.0x	0.47+0.2x	0.250.0x	0.29+0.2x	0.130.0x	0.170.0x	0.21
Asset Turnover	0.56+0.1x	0.50-0.2x	0.720.0x	0.72-0.1x	0.79+0.1x	0.680.0x	0.650.0x	0.690.0x	0.65-0.1x	0.75-0.3x	1.09-0.1x	1.17-0.1x	1.24-0.1x	1.320.0x	1.27
FCF Margin	7.2%+2.0pp	5.2%-4.8pp	10.0%+1.1pp	9.0%+1.7pp	7.3%-2.1pp	9.4%+5.2pp	4.3%-2.1pp	6.4%-0.6pp	6.9%	N/A	N/A	N/A	N/A	N/A	5.5%

Metric	Q4'2610-K	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q
Gross Margin	42.7%+1.6pp	40.9%+1.3pp	41.7%+4.0pp	41.6%+0.5pp	41.1%+2.6pp	39.7%+1.2pp	37.6%-2.5pp	41.1%+1.8pp
Operating Margin	16.4%+0.8pp	40.4%+27.8pp	16.1%+11.6pp	13.6%-0.5pp	15.6%+0.6pp	12.6%+0.3pp	4.5%-10.0pp	14.1%-0.4pp
Net Margin	9.0%+1.4pp	29.8%+19.3pp	1.0%+0.5pp	6.9%-3.8pp	7.5%-3.3pp	10.5%+1.6pp	0.4%-10.1pp	10.7%+0.5pp
Return on Equity	2.7%+0.4pp	8.9%+5.7pp	0.3%+0.2pp	2.1%-0.6pp	2.4%-0.8pp	3.2%+0.6pp	0.1%-2.9pp	2.8%-0.4pp
Return on Assets	1.3%+0.2pp	4.4%+3.0pp	0.1%+0.1pp	1.0%-0.8pp	1.1%-0.9pp	1.4%-0.2pp	0.1%-1.8pp	1.8%-0.2pp
Current Ratio	2.40-0.5x	3.05-0.4x	2.87-0.5x	2.87-0.7x	2.88-0.5x	3.400.0x	3.370.0x	3.55+0.4x
Debt-to-Equity	0.69-0.1x	0.63-0.2x	0.76-0.1x	0.77+0.5x	0.78+0.5x	0.84+0.6x	0.81+0.6x	0.230.0x
Asset Turnover	0.140.0x	0.150.0x	0.140.0x	0.140.0x	0.140.0x	0.130.0x	0.130.0x	0.160.0x
FCF Margin	15.3%+4.1pp	2.7%+1.1pp	5.8%+4.7pp	4.8%-1.6pp	11.2%-1.0pp	1.7%-9.2pp	1.1%-9.7pp	6.4%-0.1pp

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
Standex International Corporation SXI	FY2026	$891.6M	$104.6M	11.7%	$3.6B	64/100
American Superconductor Corp AMSC	FY2026	$299.2M	$133.8M	44.7%	$1.5B	58/100
Enerpac Tool Group Corp. EPAC	FY2025	$616.9M	$92.7M	15.0%	$1.8B	69/100
Power Solutions International, Inc. PSIX	FY2025	$722.4M	$114.0M	15.8%	$1.0B	66/100
Xometry, Inc. XMTR	FY2025	$686.6M	-$61.7M	-9.0%	$5.9B	48/100

Where Standex International Corporation Ranks

Frequently Asked Questions

What is Standex International Corporation's annual revenue?

Standex International Corporation (SXI) reported $891.6M in total revenue for fiscal year 2026. This represents a 12.8% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Standex International Corporation's revenue growing?

Standex International Corporation (SXI) revenue grew by 12.8% year-over-year, from $790.1M to $891.6M in fiscal year 2026.

Is Standex International Corporation profitable?

Yes, Standex International Corporation (SXI) reported a net income of $104.6M in fiscal year 2026, with a net profit margin of 11.7%.

What is Standex International Corporation's EBITDA?

Standex International Corporation (SXI) had EBITDA of $232.2M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does Standex International Corporation have?

As of fiscal year 2026, Standex International Corporation (SXI) had $178.7M in cash and equivalents against $518.0M in long-term debt.

What is Standex International Corporation's gross margin?

Standex International Corporation (SXI) had a gross margin of 41.7% in fiscal year 2026, indicating the percentage of revenue retained after direct costs of goods sold.

What is Standex International Corporation's operating margin?

Standex International Corporation (SXI) had an operating margin of 21.7% in fiscal year 2026, reflecting the profitability of core business operations before interest and taxes.

What is Standex International Corporation's net profit margin?

Standex International Corporation (SXI) had a net profit margin of 11.7% in fiscal year 2026, representing the share of revenue converted into profit after all expenses.

Does Standex International Corporation pay dividends?

Yes, Standex International Corporation (SXI) paid $1.34 per share in dividends during fiscal year 2026.

What is Standex International Corporation's return on equity (ROE)?

Standex International Corporation (SXI) has a return on equity of 13.9% for fiscal year 2026, measuring how efficiently the company generates profit from shareholder equity.

What is Standex International Corporation's free cash flow?

Standex International Corporation (SXI) generated $64.4M in free cash flow during fiscal year 2026. This represents a 56.0% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Standex International Corporation's operating cash flow?

Standex International Corporation (SXI) generated $89.6M in operating cash flow during fiscal year 2026, representing cash generated from core business activities.

What are Standex International Corporation's total assets?

Standex International Corporation (SXI) had $1.6B in total assets as of fiscal year 2026, including both current and long-term assets.

What are Standex International Corporation's capital expenditures?

Standex International Corporation (SXI) invested $25.2M in capital expenditures during fiscal year 2026, funding long-term assets and infrastructure.

How much does Standex International Corporation spend on research and development?

Standex International Corporation (SXI) invested $24.2M in research and development during fiscal year 2026.

Does Standex International Corporation buy back shares?

Yes, Standex International Corporation (SXI) spent $4.4M on share buybacks during fiscal year 2026, returning capital to shareholders by reducing shares outstanding.

How many shares does Standex International Corporation have outstanding?

Standex International Corporation (SXI) had 12M shares outstanding as of fiscal year 2026.

What is Standex International Corporation's current ratio?

Standex International Corporation (SXI) had a current ratio of 2.40 as of fiscal year 2026, which is generally considered healthy.

What is Standex International Corporation's debt-to-equity ratio?

Standex International Corporation (SXI) had a debt-to-equity ratio of 0.69 as of fiscal year 2026, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Standex International Corporation's return on assets (ROA)?

Standex International Corporation (SXI) had a return on assets of 6.6% for fiscal year 2026, measuring how efficiently the company uses its assets to generate profit.

What is Standex International Corporation's P/E ratio?

Standex International Corporation (SXI) trades at 34.0x earnings, its market capitalization divided by net income of $104.6M net income, FY2026. The market capitalization is $3.6B as of Oct 6, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Standex International Corporation's price-to-sales ratio?

Standex International Corporation (SXI) trades at 4.0x sales, its market capitalization divided by revenue of $891.6M revenue, FY2026. The market capitalization is $3.6B as of Oct 6, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Standex International Corporation's Altman Z-Score?

Standex International Corporation (SXI) has an Altman Z-Score of 4.85, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Standex International Corporation's Piotroski F-Score?

Standex International Corporation (SXI) has a Piotroski F-Score of 6 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Standex International Corporation's earnings high quality?

Standex International Corporation (SXI) has an earnings quality ratio of 0.86x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Standex International Corporation cover its interest payments?

Standex International Corporation (SXI) has an interest coverage ratio of 6.30x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Standex International Corporation?

Standex International Corporation (SXI) scores 64 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.